English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Medical epistemology lately has seen a strengthening of the view that the construction of evidence should be sensitive to the social context in which it is produced. A poignant illustration of this is the undue influence of the pharmaceutical industry on research results and reporting. I challenge a particular application of this view by examining a common practice in the medical and scientific community: mandatory author disclosure of conflicts of interest (COIs) in published articles. In illustrating problems with COI disclosure policies in biomedical publishing, including unappreciated shortcomings of the scant empirical data supporting mandatory disclosure, I hope to demonstrate that the value given to journal COI disclosure policies as a way to protect the reliability of medical evidence might well be misplaced. Rather than extract away the "messy" details of the real world, the analysis is ultimately more responsive to how medical knowledge is produced and disseminated.

Unreliable Threats: Conflicts of Interest Disclosure and the Safeguarding of Biomedical Knowledge